Home | Business News | Browse by Publication | P | Pharma Marketletter

Bracco licenses 177Lu-AMBA to Marillion.

Publication: Pharma Marketletter
Publication Date: 17-NOV-08
Format: Online
Delivery: Immediate Online Access

Article Excerpt
Italian diagnostics firm Bracco Imaging SpA has granted USA-based Marillion Pharmaceuticals exclusive worldwide rights to complete clinical development and to commercialize 177Lu-AMBA for the treatment of hormone-resistant prostate and metastatic breast cancers.

177Lu-AMBA is a targeted radiotherapeutic that utilizes a receptor-based technology that allows it to home in on...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Pharma Marketletter
Stock Commentary - Europe - week to Nov 10, 2008., November 17, 2008
Survey finds disparities in drug access across EU., November 17, 2008
AstraZeneca launches DTP scheme in Poland., November 17, 2008
EU policies "have negative" R&D impact., November 17, 2008
Only 52% of Americans plan to get flu shots this year., November 17, 2008

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.